The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies

Qiu-Yue Peng1,2,3, Ying An1,2,3, Zong-Zhe Jiang1,2,3

  • 1Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.

PubMed

Insights

Diabetic kidney disease (DKD) involves complex interactions between immune and kidney cells. Understanding these interactions can reveal new therapeutic targets for DKD treatment.

Area of Science:

  • Nephrology
  • Immunology
  • Genomics

Background:

  • Diabetic kidney disease (DKD) is a significant complication of diabetes, contributing to mortality.
  • Immune cell and cytokine dysregulation accelerates DKD progression.
  • Cell-to-cell interactions within the kidney are crucial for DKD pathogenesis.

Purpose of the Study:

  • To review molecular mechanisms of immune and renal cell interactions in DKD.
  • To discuss recent advances in single-cell technology and bioinformatics for DKD research.
  • To identify immune cells as potential therapeutic targets for DKD.

Main Methods:

  • Literature review of molecular mechanisms in DKD.
  • Analysis of recent studies utilizing single-cell technologies.
  • Examination of bioinformatics approaches in DKD research.

Main Results:

  • Detailed summary of molecular interactions between immune and renal cells in DKD.
  • Highlighting the impact of immune dysregulation on kidney pathology.
  • Integration of single-cell and bioinformatics findings.

Conclusions:

  • Immune cell interactions are central to DKD development and progression.
  • Single-cell technologies and bioinformatics offer novel insights into DKD.
  • Targeting immune cells presents a promising strategy for future DKD therapies.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
68.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
777
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K